Duchenne News Tags: Upsher-Smith

December 15, 2025
On December 1, 2025, Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of KYMBEE™ (deflazacort) Tablets, indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and...

Jett Foundation’s Silver Soirée
Thursday, June 11, 2026 | 5:30PM
Granite Links | Quincy, MA